United States Angioedema Treatment Market Report 2017

United States Angioedema Treatment Market Report 2017

1 Angioedema Treatment Overview

1.1 Product Overview and Scope of Angioedema Treatment

1.2 Classification of Angioedema Treatment

1.2.1 Antihistamines

1.2.2 Corticosteroids

1.2.3 Others

1.3 Application of Angioedema Treatment

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Research Organizations?

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Angioedema Treatment (2012-2022)

1.4.1 United States Angioedema Treatment Sales and Growth Rate (2012-2022)

1.4.2 United States Angioedema Treatment Revenue and Growth Rate (2012-2022)

2 United States Angioedema Treatment Competition by Manufacturers

2.1 United States Angioedema Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Angioedema Treatment Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Angioedema Treatment Average Price by Manufactures (2015 and 2016)

2.4 Angioedema Treatment Market Competitive Situation and Trends

2.4.1 Angioedema Treatment Market Concentration Rate

2.4.2 Angioedema Treatment Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Angioedema Treatment Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Angioedema Treatment Sales and Market Share by States (2012-2017)

3.2 United States Angioedema Treatment Revenue and Market Share by States (2012-2017)

3.3 United States Angioedema Treatment Price by States (2012-2017)

4 United States Angioedema Treatment Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Angioedema Treatment Sales and Market Share by Type (2012-2017)

4.2 United States Angioedema Treatment Revenue and Market Share by Type (2012-2017)

4.3 United States Angioedema Treatment Price by Type (2012-2017)

4.4 United States Angioedema Treatment Sales Growth Rate by Type (2012-2017)

5 United States Angioedema Treatment Sales (Volume) by Application (2012-2017)

5.1 United States Angioedema Treatment Sales and Market Share by Application (2012-2017)

5.2 United States Angioedema Treatment Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Angioedema Treatment Manufacturers Profiles/Analysis

6.1 AstraZeneca

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Angioedema Treatment Product Type, Application and Specification

6.1.2.1 Antihistamines

6.1.2.2 Corticosteroids

6.1.3 AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 F.Hoffmann-La Roche AG

6.2.2 Angioedema Treatment Product Type, Application and Specification

6.2.2.1 Antihistamines

6.2.2.2 Corticosteroids

6.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Valeant Pharmaceuticals International

6.3.2 Angioedema Treatment Product Type, Application and Specification

6.3.2.1 Antihistamines

6.3.2.2 Corticosteroids

6.3.3 Valeant Pharmaceuticals International Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 GlaxoSmithKline

6.4.2 Angioedema Treatment Product Type, Application and Specification

6.4.2.1 Antihistamines

6.4.2.2 Corticosteroids

6.4.3 GlaxoSmithKline Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 AstraZeneca

6.5.2 Angioedema Treatment Product Type, Application and Specification

6.5.2.1 Antihistamines

6.5.2.2 Corticosteroids

6.5.3 AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Sanofi SA

6.6.2 Angioedema Treatment Product Type, Application and Specification

6.6.2.1 Antihistamines

6.6.2.2 Corticosteroids

6.6.3 Sanofi SA Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Merck?Co

6.7.2 Angioedema Treatment Product Type, Application and Specification

6.7.2.1 Antihistamines

6.7.2.2 Corticosteroids

6.7.3 Merck?Co Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

7 Angioedema Treatment Manufacturing Cost Analysis

7.1 Angioedema Treatment Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Angioedema Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Angioedema Treatment Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Angioedema Treatment Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Angioedema Treatment Market Forecast (2017-2022)

11.1 United States Angioedema Treatment Sales, Revenue Forecast (2017-2022)

11.2 United States Angioedema Treatment Sales Forecast by Type (2017-2022)

11.3 United States Angioedema Treatment Sales Forecast by Application (2017-2022)

11.4 Angioedema Treatment Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Angioedema Treatment

Table Classification of Angioedema Treatment

Figure United States Sales Market Share of Angioedema Treatment by Type in 2015

Figure Antihistamines Picture

Figure Corticosteroids Picture

Figure Others Picture

Table Application of Angioedema Treatment

Figure United States Sales Market Share of Angioedema Treatment by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure Research Organizations? Examples

Figure United States Angioedema Treatment Sales and Growth Rate (2012-2022)

Figure United States Angioedema Treatment Revenue and Growth Rate (2012-2022)

Table United States Angioedema Treatment Sales of Key Manufacturers (2015 and 2016)

Table United States Angioedema Treatment Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Angioedema Treatment Sales Share by Manufacturers

Figure 2016 Angioedema Treatment Sales Share by Manufacturers

Table United States Angioedema Treatment Revenue by Manufacturers (2015 and 2016)

Table United States Angioedema Treatment Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Angioedema Treatment Revenue Share by Manufacturers

Table 2016 United States Angioedema Treatment Revenue Share by Manufacturers

Table United States Market Angioedema Treatment Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Angioedema Treatment Average Price of Key Manufacturers in 2015

Figure Angioedema Treatment Market Share of Top 3 Manufacturers

Figure Angioedema Treatment Market Share of Top 5 Manufacturers

Table United States Angioedema Treatment Sales by States (2012-2017)

Table United States Angioedema Treatment Sales Share by States (2012-2017)

Figure United States Angioedema Treatment Sales Market Share by States in 2015

Table United States Angioedema Treatment Revenue and Market Share by States (2012-2017)

Table United States Angioedema Treatment Revenue Share by States (2012-2017)

Figure Revenue Market Share of Angioedema Treatment by States (2012-2017)

Table United States Angioedema Treatment Price by States (2012-2017)

Table United States Angioedema Treatment Sales by Type (2012-2017)

Table United States Angioedema Treatment Sales Share by Type (2012-2017)

Figure United States Angioedema Treatment Sales Market Share by Type in 2015

Table United States Angioedema Treatment Revenue and Market Share by Type (2012-2017)

Table United States Angioedema Treatment Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Angioedema Treatment by Type (2012-2017)

Table United States Angioedema Treatment Price by Type (2012-2017)

Figure United States Angioedema Treatment Sales Growth Rate by Type (2012-2017)

Table United States Angioedema Treatment Sales by Application (2012-2017)

Table United States Angioedema Treatment Sales Market Share by Application (2012-2017)

Figure United States Angioedema Treatment Sales Market Share by Application in 2015

Table United States Angioedema Treatment Sales Growth Rate by Application (2012-2017)

Figure United States Angioedema Treatment Sales Growth Rate by Application (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AstraZeneca Angioedema Treatment Sales Market Share (2012-2017)

Table F.Hoffmann-La Roche AG Basic Information List

Table F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Table F.Hoffmann-La Roche AG Angioedema Treatment Sales Market Share (2012-2017)

Table Valeant Pharmaceuticals International Basic Information List

Table Valeant Pharmaceuticals International Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Table Valeant Pharmaceuticals International Angioedema Treatment Sales Market Share (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline Angioedema Treatment Sales Market Share (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Table AstraZeneca Angioedema Treatment Sales Market Share (2012-2017)

Table Sanofi SA Basic Information List

Table Sanofi SA Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sanofi SA Angioedema Treatment Sales Market Share (2012-2017)

Table Merck?Co Basic Information List

Table Merck?Co Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck?Co Angioedema Treatment Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Angioedema Treatment

Figure Manufacturing Process Analysis of Angioedema Treatment

Figure Angioedema Treatment Industrial Chain Analysis

Table Raw Materials Sources of Angioedema Treatment Major Manufacturers in 2015

Table Major Buyers of Angioedema Treatment

Table Distributors/Traders List

Figure United States Angioedema Treatment Production and Growth Rate Forecast (2017-2022)

Figure United States Angioedema Treatment Revenue and Growth Rate Forecast (2017-2022)

Table United States Angioedema Treatment Production Forecast by Type (2017-2022)

Table United States Angioedema Treatment Consumption Forecast by Application (2017-2022)

Table United States Angioedema Treatment Sales Forecast by States (2017-2022)

Table United States Angioedema Treatment Sales Share Forecast by States (2017-2022)